These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

770 related items for PubMed ID: 21725366

  • 1. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
    Chao A, Lin CY, Lee YS, Tsai CL, Wei PC, Hsueh S, Wu TI, Tsai CN, Wang CJ, Chao AS, Wang TH, Lai CH.
    Oncogene; 2012 Feb 09; 31(6):764-75. PubMed ID: 21725366
    [Abstract] [Full Text] [Related]

  • 2. An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity.
    Wynendaele J, Böhnke A, Leucci E, Nielsen SJ, Lambertz I, Hammer S, Sbrzesny N, Kubitza D, Wolf A, Gradhand E, Balschun K, Braicu I, Sehouli J, Darb-Esfahani S, Denkert C, Thomssen C, Hauptmann S, Lund A, Marine JC, Bartel F.
    Cancer Res; 2010 Dec 01; 70(23):9641-9. PubMed ID: 21084273
    [Abstract] [Full Text] [Related]

  • 3. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
    Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Uchida Y, Kawahara K, Nishiyama K, Seki N, Nakagawa M.
    Urol Oncol; 2012 Dec 01; 30(4):434-43. PubMed ID: 20843712
    [Abstract] [Full Text] [Related]

  • 4. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X, Chen S, Xiu YL, Sun KX, Zong ZH, Zhao Y.
    Mol Cancer; 2015 Feb 04; 14(1):31. PubMed ID: 25649143
    [Abstract] [Full Text] [Related]

  • 5. Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer.
    Zhou B, Xu H, Xia M, Sun C, Li N, Guo E, Guo L, Shan W, Lu H, Wu Y, Li Y, Yang D, Weng D, Meng L, Hu J, Ma D, Chen G, Li K.
    Front Med; 2017 Jun 04; 11(2):214-222. PubMed ID: 28470508
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-125b Suppresses Ovarian Cancer Progression via Suppression of the Epithelial-Mesenchymal Transition Pathway by Targeting the SET Protein.
    Ying X, Wei K, Lin Z, Cui Y, Ding J, Chen Y, Xu B.
    Cell Physiol Biochem; 2016 Jun 04; 39(2):501-10. PubMed ID: 27383536
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-106b is involved in transforming growth factor β1-induced cell migration by targeting disabled homolog 2 in cervical carcinoma.
    Cheng Y, Guo Y, Zhang Y, You K, Li Z, Geng L.
    J Exp Clin Cancer Res; 2016 Jan 15; 35():11. PubMed ID: 26769181
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation.
    Kim WK, Park M, Kim YK, Tae YK, Yang HK, Lee JM, Kim H.
    Clin Cancer Res; 2011 Dec 15; 17(24):7584-94. PubMed ID: 22042971
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
    Sarver AL, Li L, Subramanian S.
    Cancer Res; 2010 Dec 01; 70(23):9570-80. PubMed ID: 21118966
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1.
    Guo LM, Pu Y, Han Z, Liu T, Li YX, Liu M, Li X, Tang H.
    FEBS J; 2009 Oct 01; 276(19):5537-46. PubMed ID: 19702828
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
    Gwak JM, Kim HJ, Kim EJ, Chung YR, Yun S, Seo AN, Lee HJ, Park SY.
    Breast Cancer Res Treat; 2014 Aug 01; 147(1):39-49. PubMed ID: 25086633
    [Abstract] [Full Text] [Related]

  • 12. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.
    Liu M, Lang N, Chen X, Tang Q, Liu S, Huang J, Zheng Y, Bi F.
    Cancer Lett; 2011 Feb 28; 301(2):151-60. PubMed ID: 21186079
    [Abstract] [Full Text] [Related]

  • 13. [Potential role of ezrin and its related microRNA in ovarian cancer invasion and metastasis].
    Li J, Liang SH, Lu X.
    Zhonghua Fu Chan Ke Za Zhi; 2010 Oct 28; 45(10):787-92. PubMed ID: 21176563
    [Abstract] [Full Text] [Related]

  • 14. MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C.
    Li J, Wang Q, Wen R, Liang J, Zhong X, Yang W, Su D, Tang J.
    J Cell Mol Med; 2015 Dec 28; 19(12):2793-805. PubMed ID: 26283050
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2.
    Wu Q, Guo R, Lin M, Zhou B, Wang Y.
    Gynecol Oncol; 2011 Jul 28; 122(1):149-54. PubMed ID: 21529905
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers.
    Zheng B, Liang L, Huang S, Zha R, Liu L, Jia D, Tian Q, Wang Q, Wang C, Long Z, Zhou Y, Cao X, Du C, Shi Y, He X.
    Oncogene; 2012 Oct 18; 31(42):4509-16. PubMed ID: 22179828
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma.
    Xu X, Chen Z, Zhao X, Wang J, Ding D, Wang Z, Tan F, Tan X, Zhou F, Sun J, Sun N, Gao Y, Shao K, Li N, Qiu B, He J.
    Biochem Biophys Res Commun; 2012 May 18; 421(4):640-5. PubMed ID: 22450326
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.
    Qin W, Ren Q, Liu T, Huang Y, Wang J.
    FEBS Lett; 2013 May 02; 587(9):1434-9. PubMed ID: 23523916
    [Abstract] [Full Text] [Related]

  • 19. miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2.
    Ma Y, Yu S, Zhao W, Lu Z, Chen J.
    Cancer Lett; 2010 Dec 08; 298(2):150-8. PubMed ID: 20638779
    [Abstract] [Full Text] [Related]

  • 20. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.
    Sun CY, She XM, Qin Y, Chu ZB, Chen L, Ai LS, Zhang L, Hu Y.
    Carcinogenesis; 2013 Feb 08; 34(2):426-35. PubMed ID: 23104180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.